Nanthealth Current Valuation

NH
 Stock
  

USD 0.28  0.01  3.70%   

Nanthealth fundamentals help investors to digest information that contributes to Nanthealth's financial success or failures. It also enables traders to predict the movement of Nanthealth Stock. The fundamental analysis module provides a way to measure Nanthealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanthealth stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Nanthealth Current Valuation Analysis

Nanthealth's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
 2019 2020 2021 2022 (projected)
Interest Expense18.04 M19.2 M22.08 M18.12 M
Gross Profit43.29 M43.95 M50.54 M47.2 M
Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
More About Current Valuation | All Equity Analysis

Current Nanthealth Current Valuation

    
  294.75 M  
Most of Nanthealth's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanthealth is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Nanthealth Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Nanthealth is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Current Valuation. Since Nanthealth's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nanthealth's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nanthealth's interrelated accounts and indicators.

Nanthealth Current Valuation Historical Pattern

Today, most investors in Nanthealth Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nanthealth's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nanthealth current valuation as a starting point in their analysis.
   Nanthealth Current Valuation   
Share
       Timeline  
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Compare to competition

In accordance with the recently published financial statements, Nanthealth has a Current Valuation of 294.75 M. This is 97.95% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The current valuation for all United States stocks is 98.23% higher than that of the company.
Nanthealth is rated top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Health Information Services industry is now estimated at about 589.5 Million. Nanthealth totals roughly 294.75 Million in current valuation claiming about 50% of equities under Health Information Services industry.

Nanthealth Current Valuation Drivers

We derive many important indicators used in calculating different scores of Nanthealth from analyzing Nanthealth's financial statements. These drivers represent accounts that assess Nanthealth's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nanthealth's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Average Assets530.33 M361.74 M274.55 M221.18 M199.07 M273.11 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(63.19 M)(144.23 M)(50.52 M)(51.72 M)(46.55 M)(50.22 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(133.19 M)(156.35 M)(23.37 M)(19.91 M)(22.9 M)(24.7 M)
Earnings before Tax(177.41 M)(195.82 M)(63.78 M)(55.88 M)(64.26 M)(69.33 M)
Average Equity267.85 M93.3 M(37.64 M)(80.1 M)(72.09 M)(73.98 M)
Enterprise Value451.21 M235.91 M321.66 M553.84 M498.46 M498.52 M
Free Cash Flow(94.78 M)(40.18 M)(13.36 M)(22.53 M)(25.9 M)(27.95 M)
Invested Capital363.08 M251.34 M270.73 M127.53 M114.78 M175.88 M
Invested Capital Average378.11 M309.82 M265.58 M209.07 M188.16 M221.71 M
Market Capitalization330.41 M59.59 M113.94 M359.22 M323.3 M344.33 M
Tangible Asset Value265.15 M105.7 M117.33 M53.99 M48.59 M49.87 M
Working Capital46.03 M2.91 M(19.59 M)(94.16 M)(84.75 M)(86.98 M)

Nanthealth Fundamentals

About Nanthealth Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nanthealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanthealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanthealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Nanthealth operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 326 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Nanthealth without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nanthealth using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Nanthealth Piotroski F Score and Nanthealth Altman Z Score analysis. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
31 M
Quarterly Revenue Growth YOY
0.16
Return On Assets
(0.17) 
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.